GERN
Price
$1.52
Change
-$0.03 (-1.94%)
Updated
Aug 21 closing price
Capitalization
976.56M
80 days until earnings call
Intraday BUY SELL Signals
TVTX
Price
$65.71
Change
+$1.25 (+1.94%)
Updated
Aug 21 closing price
Capitalization
6.19B
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GERN vs TVTX

GERN vs TVTX Comparison Chart in %
View a ticker or compare two or three
VS
GERN vs. TVTX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GERN is a Hold and TVTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (GERN: $1.52 vs. TVTX: $65.71)
Brand notoriety: GERN and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GERN: 34% vs. TVTX: 83%
Market capitalization -- GERN: $976.56M vs. TVTX: $6.19B
GERN [@Biotechnology] is valued at $976.56M. TVTX’s [@Biotechnology] market capitalization is $6.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GERN’s FA Score shows that 0 FA rating(s) are green whileTVTX’s FA Score has 1 green FA rating(s).

  • GERN’s FA Score: 0 green, 5 red.
  • TVTX’s FA Score: 1 green, 4 red.
According to our system of comparison, TVTX is a better buy in the long-term than GERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GERN’s TA Score shows that 5 TA indicator(s) are bullish while TVTX’s TA Score has 4 bullish TA indicator(s).

  • GERN’s TA Score: 5 bullish, 3 bearish.
  • TVTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GERN is a better buy in the short-term than TVTX.

Price Growth

GERN (@Biotechnology) experienced а +3.40% price change this week, while TVTX (@Biotechnology) price change was +5.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

GERN is expected to report earnings on Nov 11, 2026.

TVTX is expected to report earnings on Oct 22, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TVTX($6.19B) has a higher market cap than GERN($977M). TVTX YTD gains are higher at: 71.971 vs. GERN (15.152). TVTX has higher annual earnings (EBITDA): 38.5M vs. GERN (-34.48M). GERN has more cash in the bank: 312M vs. TVTX (265M). GERN has less debt than TVTX: GERN (122M) vs TVTX (328M). TVTX has higher revenues than GERN: TVTX (536M) vs GERN (196M).
GERNTVTXGERN / TVTX
Capitalization977M6.19B16%
EBITDA-34.48M38.5M-90%
Gain YTD15.15271.97121%
P/E RatioN/AN/A-
Revenue196M536M37%
Total Cash312M265M118%
Total Debt122M328M37%
FUNDAMENTALS RATINGS
GERN vs TVTX: Fundamental Ratings
GERN
TVTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
9522
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
5034
P/E GROWTH RATING
1..100
6737
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TVTX's Valuation (96) in the Biotechnology industry is in the same range as GERN (100). This means that TVTX’s stock grew similarly to GERN’s over the last 12 months.

TVTX's Profit vs Risk Rating (22) in the Biotechnology industry is significantly better than the same rating for GERN (95). This means that TVTX’s stock grew significantly faster than GERN’s over the last 12 months.

GERN's SMR Rating (97) in the Biotechnology industry is in the same range as TVTX (98). This means that GERN’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's Price Growth Rating (34) in the Biotechnology industry is in the same range as GERN (50). This means that TVTX’s stock grew similarly to GERN’s over the last 12 months.

TVTX's P/E Growth Rating (37) in the Biotechnology industry is in the same range as GERN (67). This means that TVTX’s stock grew similarly to GERN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GERNTVTX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 19 days ago
76%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 13 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 6 days ago
88%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
GERN
Daily Signal:
Gain/Loss:
TVTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEVAX12.290.18
+1.49%
JHancock Disciplined Value Em Mkts Eq A
PMFPX26.610.14
+0.53%
Principal MidCap S&P 400 Index R5
CAIBX84.750.42
+0.50%
American Funds Capital Inc Bldr A
DRTCX21.760.05
+0.23%
BNY Mellon Sust US Equity I
CSGZX142.670.09
+0.06%
Columbia Seligman Global Tech Inst

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with MGTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
+1.94%
MGTX - TVTX
42%
Loosely correlated
-1.38%
VCYT - TVTX
37%
Loosely correlated
+1.24%
LGND - TVTX
37%
Loosely correlated
-0.38%
WVE - TVTX
36%
Loosely correlated
+0.76%
GERN - TVTX
33%
Loosely correlated
-1.94%
More